NCT00480454View on ClinicalTrials.gov

Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines

PHASE1CompletedINTERVENTIONAL

Enrollment

214

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

TB

Interventions

BIOLOGICAL

MVA 85A

intradermal vaccine

Trial Locations (1)

Unknown

MRC, Banjul

Sponsors

Collaborators (1)

Medical Research Council

All Listed Sponsors

collaborator

Medical Research Council

OTHER_GOV

lead

University of Oxford

OTHER